Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (31-40 of 369) with videos related to

Pageof 37
Sort By:
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Quinolones]H Lode
Chemotherapy|September 11, 2001
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpointH Lode
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Cefotaxime for the 1990sH Lode
Krankenpflege Journal|July 15, 1982
[Therapy of bronchopulmonary infections in adults]H Lode
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 3, 2008
Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. IntroductionH Lode
International Journal of Antimicrobial Agents|April 1, 1996
PrefaceH Lode
Infection|January 1, 1991
[Use and risk of antibacterial chemotherapy from the medical point of view]H Lode
Intensive Care Medicine|December 11, 2008
Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapiesH Lode
Reviews of Infectious Diseases|July 1, 1989
Pharmacokinetics and clinical results of parenterally administered new quinolones in humansH Lode
Drugs|December 20, 1999
Toxicity of quinolonesR Stahlmann, H Lode
Pageof 37

Showing results (31-40 of 369) with videos related to

Sort By:
Pageof 37
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Quinolones]H Lode
Chemotherapy|September 11, 2001
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpointH Lode
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Cefotaxime for the 1990sH Lode
Krankenpflege Journal|July 15, 1982
[Therapy of bronchopulmonary infections in adults]H Lode
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 3, 2008
Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. IntroductionH Lode
International Journal of Antimicrobial Agents|April 1, 1996
PrefaceH Lode
Infection|January 1, 1991
[Use and risk of antibacterial chemotherapy from the medical point of view]H Lode
Intensive Care Medicine|December 11, 2008
Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapiesH Lode
Reviews of Infectious Diseases|July 1, 1989
Pharmacokinetics and clinical results of parenterally administered new quinolones in humansH Lode
Drugs|December 20, 1999
Toxicity of quinolonesR Stahlmann, H Lode
Pageof 37